Covid-19 Impact on Preventable Vaccines Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Preventable Vaccines Industry

1.7 COVID-19 Impact: Preventable Vaccines Market Trends

2 Global Preventable Vaccines Quarterly Market Size Analysis

2.1 Preventable Vaccines Business Impact Assessment - COVID-19

2.1.1 Global Preventable Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Preventable Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Preventable Vaccines Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Preventable Vaccines Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Preventable Vaccines Factory Price by Manufacturers

3.3 Location of Key Manufacturers Preventable Vaccines Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Preventable Vaccines Market

3.5 Key Manufacturers Preventable Vaccines Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Preventable Vaccines Segments, By Type

4.1 Introduction

1.4.1 Adult Preventable Vaccines

1.4.2 Pediatric Preventable Vaccines

4.2 By Type, Global Preventable Vaccines Market Size, 2019-2021

4.2.1 By Type, Global Preventable Vaccines Market Size by Type, 2020-2021

4.2.2 By Type, Global Preventable Vaccines Price, 2020-2021

5 Impact of Covid-19 on Preventable Vaccines Segments, By Application

5.1 Overview

5.5.1 Bacterial Diseases

5.5.2 Virus Diseases

5.2 By Application, Global Preventable Vaccines Market Size, 2019-2021

5.2.1 By Application, Global Preventable Vaccines Market Size by Application, 2019-2021

5.2.2 By Application, Global Preventable Vaccines Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 GlaxoSmithKline

7.1.1 GlaxoSmithKline Business Overview

7.1.2 GlaxoSmithKline Preventable Vaccines Quarterly Production and Revenue, 2020

7.1.3 GlaxoSmithKline Preventable Vaccines Product Introduction

7.1.4 GlaxoSmithKline Response to COVID-19 and Related Developments

7.2 Merck

7.2.1 Merck Business Overview

7.2.2 Merck Preventable Vaccines Quarterly Production and Revenue, 2020

7.2.3 Merck Preventable Vaccines Product Introduction

7.2.4 Merck Response to COVID-19 and Related Developments

7.3 Novartis

7.3.1 Novartis Business Overview

7.3.2 Novartis Preventable Vaccines Quarterly Production and Revenue, 2020

7.3.3 Novartis Preventable Vaccines Product Introduction

7.3.4 Novartis Response to COVID-19 and Related Developments

7.4 Pfizer

7.4.1 Pfizer Business Overview

7.4.2 Pfizer Preventable Vaccines Quarterly Production and Revenue, 2020

7.4.3 Pfizer Preventable Vaccines Product Introduction

7.4.4 Pfizer Response to COVID-19 and Related Developments

7.5 Sanofi

7.5.1 Sanofi Business Overview

7.5.2 Sanofi Preventable Vaccines Quarterly Production and Revenue, 2020

7.5.3 Sanofi Preventable Vaccines Product Introduction

7.5.4 Sanofi Response to COVID-19 and Related Developments

7.6 Takeda Pharmaceutical

7.6.1 Takeda Pharmaceutical Business Overview

7.6.2 Takeda Pharmaceutical Preventable Vaccines Quarterly Production and Revenue, 2020

7.6.3 Takeda Pharmaceutical Preventable Vaccines Product Introduction

7.6.4 Takeda Pharmaceutical Response to COVID-19 and Related Developments

7.7 Abbott

7.7.1 Abbott Business Overview

7.7.2 Abbott Preventable Vaccines Quarterly Production and Revenue, 2020

7.7.3 Abbott Preventable Vaccines Product Introduction

7.7.4 Abbott Response to COVID-19 and Related Developments

7.8 Roche

7.8.1 Roche Business Overview

7.8.2 Roche Preventable Vaccines Quarterly Production and Revenue, 2020

7.8.3 Roche Preventable Vaccines Product Introduction

7.8.4 Roche Response to COVID-19 and Related Developments

7.9 AstraZeneca

7.9.1 AstraZeneca Business Overview

7.9.2 AstraZeneca Preventable Vaccines Quarterly Production and Revenue, 2020

7.9.3 AstraZeneca Preventable Vaccines Product Introduction

7.9.4 AstraZeneca Response to COVID-19 and Related Developments

7.10 Mitsubishi Tanabe Pharma

7.10.1 Mitsubishi Tanabe Pharma Business Overview

7.10.2 Mitsubishi Tanabe Pharma Preventable Vaccines Quarterly Production and Revenue, 2020

7.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Product Introduction

7.10.4 Mitsubishi Tanabe Pharma Response to COVID-19 and Related Developments

7.11 Lupin

7.11.1 Lupin Business Overview

7.11.2 Lupin Preventable Vaccines Quarterly Production and Revenue, 2020

7.11.3 Lupin Preventable Vaccines Product Introduction

7.11.4 Lupin Response to COVID-19 and Related Developments

7.12 Serum Institute of India

7.12.1 Serum Institute of India Business Overview

7.12.2 Serum Institute of India Preventable Vaccines Quarterly Production and Revenue, 2020

7.12.3 Serum Institute of India Preventable Vaccines Product Introduction

7.12.4 Serum Institute of India Response to COVID-19 and Related Developments

7.13 LG Life Sciences

7.13.1 LG Life Sciences Business Overview

7.13.2 LG Life Sciences Preventable Vaccines Quarterly Production and Revenue, 2020

7.13.3 LG Life Sciences Preventable Vaccines Product Introduction

7.13.4 LG Life Sciences Response to COVID-19 and Related Developments

7.14 S K Chemicals

7.14.1 S K Chemicals Business Overview

7.14.2 S K Chemicals Preventable Vaccines Quarterly Production and Revenue, 2020

7.14.3 S K Chemicals Preventable Vaccines Product Introduction

7.14.4 S K Chemicals Response to COVID-19 and Related Developments

7.15 Shenzhen Kangtai Biological Products

7.15.1 Shenzhen Kangtai Biological Products Business Overview

7.15.2 Shenzhen Kangtai Biological Products Preventable Vaccines Quarterly Production and Revenue, 2020

7.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Product Introduction

7.15.4 Shenzhen Kangtai Biological Products Response to COVID-19 and Related Developments

7.16 Sinovac Biotech

7.16.1 Sinovac Biotech Business Overview

7.16.2 Sinovac Biotech Preventable Vaccines Quarterly Production and Revenue, 2020

7.16.3 Sinovac Biotech Preventable Vaccines Product Introduction

7.16.4 Sinovac Biotech Response to COVID-19 and Related Developments

7.17 Janssen Pharmaceuticals

7.17.1 Janssen Pharmaceuticals Business Overview

7.17.2 Janssen Pharmaceuticals Preventable Vaccines Quarterly Production and Revenue, 2020

7.17.3 Janssen Pharmaceuticals Preventable Vaccines Product Introduction

7.17.4 Janssen Pharmaceuticals Response to COVID-19 and Related Developments

7.18 Crucell

7.18.1 Crucell Business Overview

7.18.2 Crucell Preventable Vaccines Quarterly Production and Revenue, 2020

7.18.3 Crucell Preventable Vaccines Product Introduction

7.18.4 Crucell Response to COVID-19 and Related Developments

7.19 Bavarian Nordic

7.19.1 Bavarian Nordic Business Overview

7.19.2 Bavarian Nordic Preventable Vaccines Quarterly Production and Revenue, 2020

7.19.3 Bavarian Nordic Preventable Vaccines Product Introduction

7.19.4 Bavarian Nordic Response to COVID-19 and Related Developments

7.20 Baxter

7.20.1 Baxter Business Overview

7.20.2 Baxter Preventable Vaccines Quarterly Production and Revenue, 2020

7.20.3 Baxter Preventable Vaccines Product Introduction

7.20.4 Baxter Response to COVID-19 and Related Developments

7.21 Bharat Biotech

7.21.1 Bharat Biotech Business Overview

7.21.2 Bharat Biotech Preventable Vaccines Quarterly Production and Revenue, 2020

7.21.3 Bharat Biotech Preventable Vaccines Product Introduction

7.21.4 Bharat Biotech Response to COVID-19 and Related Developments

7.22 Dynavax

7.22.1 Dynavax Business Overview

7.22.2 Dynavax Preventable Vaccines Quarterly Production and Revenue, 2020

7.22.3 Dynavax Preventable Vaccines Product Introduction

7.22.4 Dynavax Response to COVID-19 and Related Developments

7.23 Bausch Health

7.23.1 Bausch Health Business Overview

7.23.2 Bausch Health Preventable Vaccines Quarterly Production and Revenue, 2020

7.23.3 Bausch Health Preventable Vaccines Product Introduction

7.23.4 Bausch Health Response to COVID-19 and Related Developments

7.24 Protein Sciences

7.24.1 Protein Sciences Business Overview

7.24.2 Protein Sciences Preventable Vaccines Quarterly Production and Revenue, 2020

7.24.3 Protein Sciences Preventable Vaccines Product Introduction

7.24.4 Protein Sciences Response to COVID-19 and Related Developments

7.25 Panacea Biotec

7.25.1 Panacea Biotec Business Overview

7.25.2 Panacea Biotec Preventable Vaccines Quarterly Production and Revenue, 2020

7.25.3 Panacea Biotec Preventable Vaccines Product Introduction

7.25.4 Panacea Biotec Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Preventable Vaccines Supply Chain Analysis

8.1.1 Preventable Vaccines Supply Chain Analysis

8.1.2 Covid-19 Impact on Preventable Vaccines Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Preventable Vaccines Distribution Channels

8.2.2 Covid-19 Impact on Preventable Vaccines Distribution Channels

8.2.3 Preventable Vaccines Distributors

8.3 Preventable Vaccines Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Preventable Vaccines Assessment

Table 9. COVID-19 Impact: Preventable Vaccines Market Trends

Table 10. COVID-19 Impact Global Preventable Vaccines Market Size

Table 11. Global Preventable Vaccines Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Preventable Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Preventable Vaccines Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Preventable Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Preventable Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Preventable Vaccines Market Growth Drivers

Table 17. Global Preventable Vaccines Market Restraints

Table 18. Global Preventable Vaccines Market Opportunities

Table 19. Global Preventable Vaccines Market Challenges

Table 20. Key Manufacturers Preventable Vaccines Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Preventable Vaccines Market Size, 2019 (K Units) & (US$ Million)

Table 22. Preventable Vaccines Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Preventable Vaccines Manufacturing Plants

Table 24. Key Manufacturers Preventable Vaccines Market Served

Table 25. Date of Key Manufacturers Enter into Preventable Vaccines Market

Table 26. Key Manufacturers Preventable Vaccines Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Preventable Vaccines Market Size by Type, 2020, (US$ Million)

Table 29. Global Preventable Vaccines Market Size by Type, 2020 (K Units)

Table 30. Global Preventable Vaccines Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Preventable Vaccines Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Preventable Vaccines Market Size by Application, 2020-2021 (K Units)

Table 33. Global Preventable Vaccines Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Preventable Vaccines Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Preventable Vaccines Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Preventable Vaccines Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Preventable Vaccines Market Size, 2019-2021 (K Units)

Table 38. US Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Preventable Vaccines Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Preventable Vaccines Market Size, 2019-2021 (K Units)

Table 43. Germany Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Preventable Vaccines Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Preventable Vaccines Market Size, 2019-2021 (K Units)

Table 50. China Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Preventable Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. GlaxoSmithKline Business Overview

Table 58. GlaxoSmithKline Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. GlaxoSmithKline Preventable Vaccines Product

Table 60. GlaxoSmithKline Response to COVID-19 and Related Developments

Table 61. Merck Business Overview

Table 62. Merck Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Merck Preventable Vaccines Product

Table 64. Merck Response to COVID-19 and Related Developments

Table 65. Novartis Business Overview

Table 66. Novartis Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Novartis Preventable Vaccines Product

Table 68. Novartis Response to COVID-19 and Related Developments

Table 69. Pfizer Business Overview

Table 70. Pfizer Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Pfizer Preventable Vaccines Product

Table 72. Pfizer Response to COVID-19 and Related Developments

Table 73. Sanofi Business Overview

Table 74. Sanofi Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Sanofi Preventable Vaccines Product

Table 76. Sanofi Response to COVID-19 and Related Developments

Table 77. Takeda Pharmaceutical Business Overview

Table 78. Takeda Pharmaceutical Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Takeda Pharmaceutical Preventable Vaccines Product

Table 80. Takeda Pharmaceutical Response to COVID-19 and Related Developments

Table 81. Abbott Business Overview

Table 82. Abbott Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Abbott Preventable Vaccines Product

Table 84. Abbott Response to COVID-19 and Related Developments

Table 85. Roche Business Overview

Table 86. Roche Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Roche Preventable Vaccines Product

Table 88. Roche Response to COVID-19 and Related Developments

Table 89. AstraZeneca Business Overview

Table 90. AstraZeneca Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. AstraZeneca Preventable Vaccines Product

Table 92. AstraZeneca Response to COVID-19 and Related Developments

Table 93. Mitsubishi Tanabe Pharma Business Overview

Table 94. Mitsubishi Tanabe Pharma Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Mitsubishi Tanabe Pharma Preventable Vaccines Product

Table 96. Mitsubishi Tanabe Pharma Response to COVID-19 and Related Developments

Table 97. Lupin Business Overview

Table 98. Lupin Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Lupin Preventable Vaccines Product

Table 100. Lupin Response to COVID-19 and Related Developments

Table 101. Serum Institute of India Business Overview

Table 102. Serum Institute of India Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Serum Institute of India Preventable Vaccines Product

Table 104. Serum Institute of India Response to COVID-19 and Related Developments

Table 105. LG Life Sciences Business Overview

Table 106. LG Life Sciences Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. LG Life Sciences Preventable Vaccines Product

Table 108. LG Life Sciences Response to COVID-19 and Related Developments

Table 109. S K Chemicals Business Overview

Table 110. S K Chemicals Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. S K Chemicals Preventable Vaccines Product

Table 112. S K Chemicals Response to COVID-19 and Related Developments

Table 113. Shenzhen Kangtai Biological Products Business Overview

Table 114. Shenzhen Kangtai Biological Products Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 115. Shenzhen Kangtai Biological Products Preventable Vaccines Product

Table 116. Shenzhen Kangtai Biological Products Response to COVID-19 and Related Developments

Table 117. Sinovac Biotech Business Overview

Table 118. Sinovac Biotech Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 119. Sinovac Biotech Preventable Vaccines Product

Table 120. Sinovac Biotech Response to COVID-19 and Related Developments

Table 121. Janssen Pharmaceuticals Business Overview

Table 122. Janssen Pharmaceuticals Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 123. Janssen Pharmaceuticals Preventable Vaccines Product

Table 124. Janssen Pharmaceuticals Response to COVID-19 and Related Developments

Table 125. Crucell Business Overview

Table 126. Crucell Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 127. Crucell Preventable Vaccines Product

Table 128. Crucell Response to COVID-19 and Related Developments

Table 129. Bavarian Nordic Business Overview

Table 130. Bavarian Nordic Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 131. Bavarian Nordic Preventable Vaccines Product

Table 132. Bavarian Nordic Response to COVID-19 and Related Developments

Table 133. Baxter Business Overview

Table 134. Baxter Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 135. Baxter Preventable Vaccines Product

Table 136. Baxter Response to COVID-19 and Related Developments

Table 137. Bharat Biotech Business Overview

Table 138. Bharat Biotech Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 139. Bharat Biotech Preventable Vaccines Product

Table 140. Bharat Biotech Response to COVID-19 and Related Developments

Table 141. Dynavax Business Overview

Table 142. Dynavax Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 143. Dynavax Preventable Vaccines Product

Table 144. Dynavax Response to COVID-19 and Related Developments

Table 145. Bausch Health Business Overview

Table 146. Bausch Health Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 147. Bausch Health Preventable Vaccines Product

Table 148. Bausch Health Response to COVID-19 and Related Developments

Table 149. Protein Sciences Business Overview

Table 150. Protein Sciences Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 151. Protein Sciences Preventable Vaccines Product

Table 152. Protein Sciences Response to COVID-19 and Related Developments

Table 153. Panacea Biotec Business Overview

Table 154. Panacea Biotec Preventable Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 155. Panacea Biotec Preventable Vaccines Product

Table 156. Panacea Biotec Response to COVID-19 and Related Developments

Table 157. Preventable Vaccines Distributors List

Table 158. Preventable Vaccines Customers List

Table 159. Covid-19 Impact on Preventable Vaccines Customers

List of Figures

Figure 1. Preventable Vaccines Product Picture

Figure 2. Preventable Vaccines Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Preventable Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Preventable Vaccines Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Preventable Vaccines Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Preventable Vaccines Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Preventable Vaccines Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Preventable Vaccines Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Preventable Vaccines Market Size Market Share, 2019-2021